🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

7 recruiting trials

for High-Grade Osteosarcoma

Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse NCT07871864Phase 377 sites📍 Aarhus📍 Aarhus📍 Copenhagen Gustave Roussy, Cancer Campus, Grand Paris · Tests: Experimental group : Cabometyx ® 40mg/m2/day (Max: 60mg/day) , Treatment schedule : Daily**, day 1-28 during 4 weeks (i… Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). NCT06607692Phase 1, Phase 21 site📍 Boadilla del Monte Fundación de investigación HM · Tests: Olaparib; 177Lu-DOTATATE A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intravenously in Patients With Advanced High-Grade Osteosarcoma NCT06650514Phase 21 site📍 Barcelona Vall d'Hebron Institute of Oncology · Tests: OMO-103 An Observational Study of Local Relapse After High Grade Osteosarcoma NCT06017518n/a2 sites📍 Bologna📍 Pisa Istituto Ortopedico Rizzoli Treatment Patterns and Survival Outcomes in High-Grade Osteosarcoma: A Multicenter Retrospective Study NCT07878364n/a4 sites📍 Goyang-si📍 Seoul📍 Seoul MedPacto, Inc. Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients NCT04698785Phase 216 sites📍 Besançon📍 Bordeaux📍 Dijon Centre Leon Berard · Tests: Treatment by regorafenib and best supportive care Upfront Surgical Resection for Osteosarcoma NCT06384404n/a1 site📍 The Bronx Montefiore Medical Center · Tests: Questionnaire
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy